Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride
Loading drug information...
⚠️
Failed to Load Drug Information
Please check your internet connection and try again.
Last updated: June 2025
For educational purposes only
Clinical Reference
# Potassium Chloride
## Overview
Potassium chloride (KCL) is an essential electrolyte. It is crucial for maintaining fluid balance, nerve impulse transmission, and muscle contraction. It is available in oral and intravenous formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
* Prevention of hypokalemia in patients receiving thiazide or loop diuretics.
* Potassium replacement in various clinical conditions causing potassium loss (e.g., severe vomiting, diarrhea, certain kidney diseases).
## Adult Dosing
* **Oral:** Dosing is highly individualized based on serum potassium levels and clinical assessment.
* **Prevention of Hypokalemia:** Typically 20 mEq (1000 mg) per day, divided into 1-2 doses.
* **Treatment of Hypokalemia:** Initial doses may range from 40-100 mEq (2000-5000 mg) per day, divided into 2-4 doses. Higher doses may be required under close medical supervision.
* Maximum oral dose is generally not rigidly defined but should not exceed what is necessary to correct hypokalemia safely. Sustained-release formulations are often preferred to reduce gastrointestinal irritation.
* **Intravenous (IV):** Dosing is determined by serum potassium level, severity of symptoms, and rate of correction desired.
* **Mild Hypokalemia:** Typically 20-40 mEq (1000-2000 mg) per 24 hours.
* **Moderate Hypokalemia:** May require 40-80 mEq (2000-4000 mg) per 24 hours.
* **Severe Hypokalemia:** Doses up to 100-120 mEq (5000-6000 mg) per 24 hours may be necessary, administered in critical care settings with continuous cardiac monitoring.
* **Maximum IV Rate:** Generally **not to exceed 10 mEq (500 mg) per hour** peripherally, and **not to exceed 20 mEq (1000 mg) per hour centrally** for severe, symptomatic hypokalemia, with continuous cardiac monitoring. Local protocols may vary.
* **Maximum IV Concentration:** Peripheral administration is typically limited to **10 mEq (500 mg) per 100 mL**, not to exceed **40 mEq (2000 mg) per 1000 mL** bag. Central administration can tolerate higher concentrations, up to 200 mEq (10000 mg) in 1 L, depending on clinical scenario and monitoring.
## Pediatric Dosing
* Dosing is based on body weight and serum potassium levels.
* **Oral:** Typically 1-2 mEq/kg/day (50-100 mg/kg/day), divided into 2-4 doses. Maximum daily dose is usually **100 mEq (5000 mg)**.
* **Intravenous (IV):**
* **Prevention:** 0.5-1 mEq/kg/day (25-50 mg/kg/day), not to exceed adult maintenance.
* **Treatment:** 1-2 mEq/kg/dose (50-100 mg/kg/dose) over 1-3 hours, not to exceed 10 mEq/dose (500 mg/dose) per dose or 20 mEq (1000 mg) per 24 hours in infants. For older children, higher doses may be used but require careful monitoring.
* **Maximum IV Rate:** Generally **0.5 mEq/kg/hour (25 mg/kg/hour)**, not to exceed **10 mEq/hour (500 mg/hour)**. In life-threatening situations, rates up to 1 mEq/kg/hour (50 mg/kg/hour) may be used with continuous cardiac monitoring. Local protocols are crucial.
* **Maximum IV Concentration:** Generally **40 mEq/L (2000 mg/L)**.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Potassium excretion is impaired. Monitor serum potassium closely. Higher doses may be required for replacement but risk of hyperkalemia is significantly increased. Dose reduction or discontinuation is often necessary.
* **Hepatic Impairment:** No specific dose adjustment, but monitor electrolytes as liver dysfunction can affect electrolyte balance.
## Contraindications
* Hyperkalemia.
* Conditions where potassium retention is common (e.g., severe renal impairment, untreated Addison's disease, severe burns, extensive tissue injury).
* Certain cardiac conduction abnormalities or ECG changes suggestive of hyperkalemia.
* Known hypersensitivity to potassium chloride.
## Adverse Effects
* **Gastrointestinal (Oral):** Nausea, vomiting, diarrhea, abdominal pain, gastric irritation, ulceration, bleeding.
* **Cardiovascular (IV, especially with rapid administration or overdose):** Arrhythmias, cardiac arrest, hypotension.
* **Other:** Hyperkalemia (can be asymptomatic or manifest with weakness, paresthesias, confusion, fatigue, ECG changes, and ultimately cardiac arrest). Phlebitis or extravasation with IV administration.
## Key Drug Interactions
* **ACE Inhibitors, ARBs, Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene), NSAIDs, Heparin, Trimethoprim:** Increased risk of hyperkalemia.
* **Thiazide and Loop Diuretics:** Can cause hypokalemia, necessitating potassium supplementation, but monitor potassium closely as interactions can be complex.
* **Digoxin:** Hypokalemia increases the risk of digoxin toxicity. Hyperkalemia reduces digoxin's efficacy.
* **Neuromuscular Blocking Agents:** Potassium affects neuromuscular transmission; changes in potassium levels can alter responses.
## Monitoring
* **Serum Potassium Levels:** Crucial, especially during IV therapy and with dose adjustments. Frequency depends on severity of hypokalemia and route of administration.
* **Renal Function (BUN, Creatinine):** Assess for underlying renal impairment.
* **ECG:** Monitor for changes indicative of hypokalemia (e.g., flattened T waves, U waves) or hyperkalemia (e.g., peaked T waves, widened QRS). This is particularly important during rapid IV potassium administration.
* **Fluid Balance:** Monitor intake and output.
* **Signs and Symptoms of Hypo/Hyperkalemia.**
## Clinical Pearls
* Oral potassium chloride, particularly in solid forms, can be irritating to the gastrointestinal tract. Taking with food or diluting liquid formulations can minimize this.
* IV potassium should always be administered with caution and appropriate monitoring. Never administer IV push.
* Hyperkalemia is a medical emergency. Rapid administration of IV potassium chloride is dangerous and should only be done in critical care settings with continuous cardiac monitoring.
* Correcting severe hypokalemia can be challenging and requires careful titration and monitoring.
* Ensure adequate magnesium levels, as magnesium deficiency can impair potassium repletion.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information, institutional protocols, and clinical guidelines before making any treatment decisions.